LONDON, Dec 30 (Reuters) - The AstraZeneca-Oxford COVID-19
vaccine approved by Britain on Wednesday should be effective
against a rapidly spreading new variant of the virus,
AstraZeneca's Chief Executive Pascal Soriot said.
"Our belief at this point is that this vaccine should be
effective against the variant," he told BBC radio.
(Reporting by Paul Sandle, editing by William James)